Literature DB >> 21173137

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

Véronique J Hofman1, Marius I Ilie, Christelle Bonnetaud, Eric Selva, Elodie Long, Thierry Molina, Jean Michel Vignaud, Jean François Fléjou, Sylvie Lantuejoul, Eric Piaton, Catherine Butori, Nathalie Mourad, Michel Poudenx, Philippe Bahadoran, Stéphanie Sibon, Nicolas Guevara, José Santini, Nicolas Vénissac, Jérôme Mouroux, Philippe Vielh, Paul M Hofman.   

Abstract

Detection of circulating tumor cells (CTCs) morphologically may be a promising new approach in clinical oncology. We tested the reliability of a cytomorphologic approach to identify CTCs: 808 blood samples from patients with benign and malignant diseases and healthy volunteers were examined using the isolation by size of epithelial tumor cell (ISET) method. Cells having nonhematologic features (so-called circulating nonhematologic cells [CNHCs]) were classified into 3 categories: CNHCs with malignant features, CNHCs with uncertain malignant features, and CNHCs with benign features. CNHCs were found in 11.1% and 48.9% of patients with nonmalignant and malignant pathologies, respectively (P < .001). CNHCs with malignant features were observed in 5.3% and in 43.1% of patients with nonmalignant and malignant pathologies, respectively. Cytopathologic identification of CTCs using the ISET method represents a promising field for cytopathologists. The possibility of false-positive diagnosis stresses the need for using ancillary methods to improve this approach.

Entities:  

Mesh:

Year:  2011        PMID: 21173137     DOI: 10.1309/AJCP9X8OZBEIQVVI

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  63 in total

1.  Inertia based microfluidic capture and characterisation of circulating tumour cells for the diagnosis of lung cancer.

Authors:  Dimple Y Chudasama; Daria V Freydina; Maxim B Freidin; Maria Leung; Angeles Montero Fernandez; Alexandra Rice; Andrew G Nicholson; Emmanouil Karteris; Vladimir Anikin; Eric Lim
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Circulating tumor cell enrichment based on physical properties.

Authors:  Ramdane A Harouaka; Merisa Nisic; Si-Yang Zheng
Journal:  J Lab Autom       Date:  2013-07-05

3.  Circulating tumor cells as lung cancer biomarkers.

Authors:  Maria P Wong
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

4.  Real-Time qPCR-Based Detection of Circulating Tumor Cells from Blood Samples of Adjuvant Breast Cancer Patients: A Preliminary Study.

Authors:  Ulrich Andergassen; Michael Zebisch; Alexandra C Kölbl; Alexander König; Sabine Heublein; Lennard Schröder; Stefan Hutter; Klaus Friese; Udo Jeschke
Journal:  Breast Care (Basel)       Date:  2016-06-15       Impact factor: 2.860

5.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 6.  The current status of the clinical utility of liquid biopsies in cancer.

Authors:  Anson Snow; Denaly Chen; Julie E Lang
Journal:  Expert Rev Mol Diagn       Date:  2019-09-08       Impact factor: 5.225

Review 7.  Circulating tumor cells in sarcomas: a brief review.

Authors:  Le Chang; Greg Asatrian; Sarah M Dry; Aaron W James
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

Review 8.  Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Authors:  Marius Ilie; Véronique Hofman; Elodie Long; Olivier Bordone; Eric Selva; Kevin Washetine; Charles Hugo Marquette; Paul Hofman
Journal:  Ann Transl Med       Date:  2014-11

9.  Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.

Authors:  Yue Yu; Zhaoli Chen; Jingsi Dong; Peng Wei; Rongjun Hu; Chengcheng Zhou; Nan Sun; Mei Luo; Wenjing Yang; Ran Yao; Yibo Gao; Jiagen Li; Guohua Yang; Wei He; Jie He
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

10.  Surface-micromachined microfiltration membranes for efficient isolation and functional immunophenotyping of subpopulations of immune cells.

Authors:  Weiqiang Chen; Nien-Tsu Huang; Boram Oh; Raymond H W Lam; Rong Fan; Timothy T Cornell; Thomas P Shanley; Katsuo Kurabayashi; Jianping Fu
Journal:  Adv Healthc Mater       Date:  2013-01-20       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.